Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation | MicrobiomeTrials← Back to trialsNCT06942039
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2025-09-23Est. Completion: 2030-12-31
Enrollment target: 15 participants Locations- Alberta Children's Hospital, Calgary, Alberta, Canada
- BC Children's Hospital, Vancouver, British Columbia, Canada
- CancerCare Manitoba (CCMB), Winnipeg, Manitoba, Canada
- IWK Health Centre, Halifax, Nova Scotia, Canada
- McMaster Children's Hospital, Hamilton, Ontario, Canada
- London Health Sciences Centre, London, Ontario, Canada
- CHU Sainte-Justine, Montreal, Quebec, Canada
- Montreal Children's Hospital (McGill), Montreal, Quebec, Canada
- CHU de Québec-Université Laval, Québec, Quebec, Canada
- Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada
- Stollery Children's Hospital, Edmonton, Canada
- The Hospital for Sick Children, Toronto, Canada
Other microbiome trials you might be interested in
Malignant Brain NeoplasmMalignant Solid NeoplasmMultiple SclerosisNeuroendocrine TumorProstate Carcinoma
This clinical trial studies the effect of respiratory training for enhancing brain and mental health among patients with…
Rochester, United StatesEst. completion Jan 18, 2027
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic AstrocytomaGlioblastomaGlioblastoma MultiformeDiffuse Midline Glioma, H3 K27M-Mutant
Metastatic Brain Tumor
WHO Grade III Glioma
WHO Grade IV Glioma
The goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult pati…
Aurora, United StatesEst. completion Aug 28, 2029
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch SyndromeRecurrent LymphomaRecurrent Malignant Solid NeoplasmRecurrent NeuroblastomaRecurrent Primary Central Nervous System NeoplasmRefractory LymphomaRefractory Malignant Solid NeoplasmRefractory NeuroblastomaRefractory Primary Central Nervous System NeoplasmXeroderma Pigmentosum
This phase Ib trial investigates the side effects of the combination of nivolumab and ipilimumab, and to see how well th…
Palo Alto, United StatesCompleted Jun 21, 2022